Ares Life Sciences

Ares Life Sciences is an expansion and later stage private equity fund set up by the Bertarelli family with €500 million under management that invests in world class life science companies.

The fund is focused on five specific sectors: Pharmaceuticals, Biotechnology, Diagnostics, Medical Technology and Healthcare services.

Ares Life Sciences aims to add value to its portfolio of companies through a management team that provides exceptional sector experience, investment expertise, scientific knowledge and industry networks.

26.11.2009

Esaote, world leading company in the production of medical technologies, has been presented the prize “China Awards 2009” for the category “Creatori di Valore” at a gala ...

16.11.2009

Esaote to be acquired by a new consortium of investors led by Ares Life Sciences, holding 40% of the share capital, with the former stake holders keeping a 60% stake.